What is Itonis Inc?
, a development stage company, focuses on producing and marketing over the counter and prescription homeopathic preparations to treat common ailments and chronic diseases.
ITNS · Verdict
Limited reward · elevated risk
ITNS's standout is volatility; cash flow and profitability weigh on the picture.
Based on 88% data coverage
ITNS · Verdict
Top decile vs peers
-32504% free-cash-flow margin
-2799% net margin · 0% ROE
Rev -57.3% CAGR · earnings -48.7%
Current ratio 0.11
Model-based scoring. For information only — not financial advice.
, a development stage company, focuses on producing and marketing over the counter and prescription homeopathic preparations to treat common ailments and chronic diseases. The company intends to sells its over-the-counter to alleviate mild to moderate nausea. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 761.70K.
The scoring profile indicates weak reward characteristics across most factors, including valuation and momentum. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.
For informational purposes only. Not financial advice.